28 Sep, 2016
  • ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage drug development company advancing targeted therapeutics for the treatment of patients with cancer, today announced that it has obtained an ...

New Warburg project at the intersection of sciences and humanities

World expert on psychology and cognitive neurosciences Professor Manos Tsakiris has been named as the first recipient of the Nomis Foundation Award. Read more...

Feature

Sir John Cass’s Foundation Distance Learning Scholarship Programme

A new scholarship programme has been created to support 18 young people living in London to study for a University of London undergraduate degree by distance and flexible learning.